In the past week, HSTM stock has gone up by 7.05%, with a monthly decline of -0.08% and a quarterly plunge of -2.69%. The volatility ratio for the week is 4.30%, and the volatility levels for the last 30 days are 2.60% for Healthstream Inc The simple moving average for the past 20 days is 4.64% for HSTM’s stock, with a 7.43% simple moving average for the past 200 days.
Is It Worth Investing in Healthstream Inc (NASDAQ: HSTM) Right Now?
Healthstream Inc (NASDAQ: HSTM) has a higher price-to-earnings ratio of 53.24x compared to its average ratio. HSTM has 36-month beta value of 0.40. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 3 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for HSTM is 23.72M, and currently, short sellers hold a 1.02% ratio of that float. The average trading volume of HSTM on April 24, 2024 was 105.60K shares.
HSTM) stock’s latest price update
The stock of Healthstream Inc (NASDAQ: HSTM) has increased by 9.54 when compared to last closing price of 24.11.Despite this, the company has seen a gain of 7.05% in its stock price over the last five trading days. Seeking Alpha reported 2024-04-23 that HealthStream, Inc. (NASDAQ:HSTM ) Q1 2024 Earnings Conference Call April 23, 2024 9:00 AM ET Company Participants Mollie Condra – Vice President of Investor Relations and Communications Bobby Frist – Chief Executive Officer Scotty Roberts – Chief Financial Officer and Senior Vice President, Accounting and Finance Conference Call Participants Matt Hewitt – Craig-Hallum Jared Haase – William Blair and Company Richard Close – Canaccord Genuity Constantine Davides – Citizens JMP Vincent Colicchio – Barrington Research Stephanie Davis – Barclays Operator Good morning, and welcome to HealthStream’s First Quarter 2024 Earnings Conference Call. At this time, I would like to inform you that this conference is being recorded and that all participants are in a listen-only mode.
Analysts’ Opinion of HSTM
Many brokerage firms have already submitted their reports for HSTM stocks, with Barclays repeating the rating for HSTM by listing it as a “Overweight.” The predicted price for HSTM in the upcoming period, according to Barclays is $32 based on the research report published on January 03, 2024 of the current year 2024.
HSTM Trading at 0.91% from the 50-Day Moving Average
After a stumble in the market that brought HSTM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.31% of loss for the given period.
Volatility was left at 2.60%, however, over the last 30 days, the volatility rate increased by 4.30%, as shares surge +1.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.58% lower at present.
During the last 5 trading sessions, HSTM rose by +7.05%, which changed the moving average for the period of 200-days by +14.58% in comparison to the 20-day moving average, which settled at $25.26. In addition, Healthstream Inc saw -2.29% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HSTM starting from Sousa Michael, who sale 15,000 shares at the price of $27.25 back on Feb 26 ’24. After this action, Sousa Michael now owns 42,525 shares of Healthstream Inc, valued at $408,750 using the latest closing price.
Coady Trisha L, the Senior Vice President of Healthstream Inc, sale 7,000 shares at $26.34 during a trade that took place back on Feb 22 ’24, which means that Coady Trisha L is holding 14,693 shares at $184,360 based on the most recent closing price.
Stock Fundamentals for HSTM
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.62 for the gross margin
The net margin for Healthstream Inc stands at 0.06. The total capital return value is set at 0.05. Equity return is now at value 4.51, with 3.05 for asset returns.
Based on Healthstream Inc (HSTM), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at 3.3. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is 75.27.
Currently, EBITDA for the company is 57.09 million with net debt to EBITDA at -0.54. When we switch over and look at the enterprise to sales, we see a ratio of 2.71. The receivables turnover for the company is 6.42for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.10.
Conclusion
To put it simply, Healthstream Inc (HSTM) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
